Medtronic Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 decreased by 0.2% to $1.16B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 49.6%, from $778.00M to $1.16B.
Significant deviations between fair value and amortized cost in this bucket highlight long-term interest rate risk exposure.
This represents the fair market value of debt securities in the available-for-sale portfolio that have maturity dates be...
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_2a379c| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.82B | $1.65B | $1.54B | $1.10B | $899.00M | $875.00M | $761.00M | $706.00M | $713.00M | $681.00M | $749.00M | $778.00M | $1.11B | $1.17B | $1.16B |
| QoQ Change | — | -9.4% | -6.4% | -28.4% | -18.4% | -2.7% | -13.0% | -7.2% | +1.0% | -4.5% | +10.0% | +3.9% | +42.5% | +5.1% | -0.2% |
| YoY Change | — | — | — | -39.4% | -45.4% | -43.2% | -30.9% | -21.5% | -18.5% | -10.5% | +6.1% | +9.1% | +62.8% | +55.7% | +49.6% |